Wnt signaling function in Alzheimer's disease

Brain Research Reviews

Volumn 33, Issue 1, 2000, Pages 1-12

  De Ferrari and, Giancarlo V ^a   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

amyloid; Alzheimer's disease; Cytoskeletal change; Neuronal degeneration; Wnt signal transduction pathway

Indexed keywords

AMYLOID BETA PROTEIN; BETA CATENIN; CELL ADHESION MOLECULE; CYTOSKELETON PROTEIN; FLAVINE ADENINE NUCLEOTIDE; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN DEVELOPMENT; CELLULAR DISTRIBUTION; HUMAN; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; HUMANS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0033850796     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(00)00021-7     Document Type: Review

References (148)

1. H. Aberle, A. Bauer, J. Stappert, A. Kispert, R. Kemler, b-catenin is a target for the ubiquitin-proteasome pathway, EMBO J. 16 (1997) 3797-3804.
2. A.D. Alonso, I. Grundke-Iqbal, H.S. Barra, K. Iqbal, Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau, Proc. Natl. Acad. Sci. USA 94 (1997) 298-303.
3. A. Alvarez, C. Opazo, R. Alarcón, J. Garrido, N.C. Inestrosa, Acetylcholinesterase promotes the aggregation of amyloid-b-peptide fragments by forming a complex with the growing fibrils, J. Mol. Biol. 272 (1997) 348-361.
4. A. Alvarez, R. Alarcoon, C. Opazo et al., Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils, J. Neurosci. 18 (1998) 3213-3223.
5. G. Alvarez, J.R. Muñoz-Montano, J. Satrústegui, J. Avila, E. Bogónez, J. Diaa-Nidd,Lithium prrttectculturre nnurrosaagims β-amyloid-induced neurodegeneration, FEBS Lett. 453 (1999) 260264.
6. B.H. Anderton, J.P. Brion, A.M. Couck et al., Modulation of PHF-like tau phosphorylation in cultured neurons and transfected cells, Neurobiol. Aging 16 (1995) 389-397.
7. P.V. Arriagada, K. Marzloff, B.T. Hyman, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology 42 (1992) 1681-1688.
8. P.V. Arriagada, J.H. Growdon, E.T. Hedley-Whyte, B.T. Hyman, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology 42 (1992) 631-639.
9. J.D. Axelrod, K. Matsuno, S. Artavanis-Tsakonas, N. Perrimon, Interaction between Wingless and Notch signaling pathways mediated by Dishevelled, Science 271 (1996) 1826-1831.
10. J.D. Axelrod, J.R. Miller, J.M. Shulman, R.T. Moon, N. Perrimon, Differential recruitment of Dishevelled provides signaling specificity in the planar cell polarity and Wingless signaling pathways, Genes Dev. 12 (1998) 2610-2622.
11. J.D. Begley, W. Duan, S. Chan, K. Duff, M.P. Mattson, Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice, J. Neurochem. 72 (1999) 1030-1039.
12. O. Berezovska, M.Q. Xia, B.T. Hyman, Notch is expressed in adult brain, is coexpressed with presenilin-1, and is altered in Alzheimer disease, J. Neuropathol. Exp. Neurol. 57 (1998) 738-745.
13. D.R. Borchelt, Metabolism of presenilin 1: influence of presenilin 1 on amyloid precursor protein processing, Neurobiol. Aging 19 (1998)S15-S18.
14. M. Boutros, N. Paricio, D.I. Strutt, M. Mlodzik, Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling, Cell 94 (1998) 109-118.
15. H. Braak, E. Braak, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol. 82 (1991) 239-259.
16. H. Braak, E. Braak, Staging of Alzheimer's disease-related neuro-fibrillary changes, Neurobiol. Aging 16 (1995) 271-284.
17. F.C. Bronfman, H.L. Fernandez, N.C. Inestrosa, Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line, Exp. Cell Res. 229 (1996) 93-99.
18. F.C. Bronfman, J. Garrido, A. Alvarez, C. Morgan, N.C. Inestrosa, Laminin inhibits amyloid-β-peptide fibrillation, Neurosci. Lett. 218 (1996) 201-203.
19. F.C. Bronfman, A. Alvarez, C. Morgan, N.C. Inestrosa, Laminin blocks the assembly of wild-type Ab and the Dutch variant peptide into Alzheimer's fibrils, Amyloid 5 (1998) 16-23.
20. F.C. Bronfman, C. Soto, L. Tapia, V. Tapia, N.C. Inestrosa, Extracellular matrix regulates the amount of the β-amyloid precursor protein and its amyloidogenic fragments, J. Cell. Physiol. 166 (1996) 360-369.
21. J.D. Brown, R.T. Moon, Wnt signaling: why is everything so negative?, Curr. Op. Cell Biol. 10 (1998) 182-187.
22. L.C. Bullions, A.J. Levine, The role of β-catenin in cell adhesion, signal transduction, and cancer, Curr. Op. Oncol. 10 (1998) 81-87.
23. J. Busciglio, A. Lorenzo, J. Yeh, β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding, Neuron 14 (1995) 879-888.
24. F.H. Calderón, A. Bonnefont, F.J. Muñoz,V Fernandez, L.A.Videla, N.C. Inestrosa, PC12 and Neuro 2a cells have different susceptibilities to acetylcholinesterase-amyloid complexes, amyloid 2535 fragment, glutamate, and hydrogen peroxide, J. Neurosci. Res. 56 (1999)620-631.
25. E. Chalecka-Franaszek, D.M. Chuang, Lithium activates the serineI threonine kinase akt-1 and suppresses glutamate-induced inhibition of akt-1 activity in neurons, Proc. Natl. Acad. Sci. USA 96 (1999) 8745-8750.
26. L.-P. Choo-Smith, W. Garzon-Rodriguez, C.G. Glabe, W.K. Surewicz, Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles, J. Biol. Chem. 272 (1997) 22987-22990.
27. G. Cole, K.R. Dobkins, L.A. Hansen, R.D. Terry, T. Saitoh, Decreased levels of protein kinase C in Alzheimer brain, Brain Res. 452 (1988) 165-174.
28. D. Cook, M.J. Fry, K. Hughes, R. Sumathipala, J.R. Woodget, T.C. Dale, Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling which involves a protein kinase C, EMBO J. 15 (1996) 4526-4536.
29. D. Cotter, R. Kerwin, S. al-Sarraji et al., Abnormalities of Wnt signalling in schizophrenia - Evidence for neurodevelopmental abnormality, Neuroreport 9 (1998) 1379-1383.
30. R.F. Cowburn, C.J. Fowler, C. O'Neill, Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease, Acta Neurol. Scand. Suppl. 165 (1996) 25-32.
31. B.J. Cummings, C.J. Pike, R. Shankle, C.W. Cotman, β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease, Neurobiol. Aging 17 (1996) 921-933.
32. T.C. Dale, Signal transduction by the Wnt family of ligands, Biochem. J. 329 (1998) 209-223.
33. G.V. De Ferrari, J. Godoy, S. Lienlaff, N.C. Inestrosa, Lithium attenuates the neurotoxic effect induced by amyloid β-peptide fibrils and Aβ-acetylcholinesterase complexes, J. Neurosci. (2000) submitted for publication.
34. S.M. de la Monte, Y.K. Sohn, N. Ganju, J.R. Wands, P53- and CD95-associated apoptosis in neurodegenerative diseases, Lab. Invest. 78 (1998) 401-411.
35. B. De Strooper, P. Saftig, K. Craessaerts et al., Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature 391 (1998) 387-390.
36. B. De Strooper, W. Annaert, P. Cupers et al., A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain, Nature 398 (1999) 518-522.
37. N.N. Dewji, S.J. Singer, Specific intercellular binding of the β-amyloid precursor protein to the presenilins induces intercellular signaling: Its significance for Alzheimer's disease, Proc. Natl. Acad. Sci. USA 95 (1998) 15055-15060.
38. A. Favit, M. Grimaldi, T.J. Nelson, D.L. Alkon, Alzheimer's-specific effects of soluble β-amyloid on protein kinase C -α and -g degradation in human fibroblasts, Proc. Natl. Acad. Sci. USA 95 (1998) 5562-5567.
39. C.E. Finch, D.M. Cohen, Aging, metabolism, and Alzheimer's disease: Review and hypothesis, Exp. Neurol. 143 (1997) 82-102.
40. S.Y. Fuchs, V. Adler, T. Buschmann, Z. Yin, X. Wu, S.N. Jones, Z. Ronai, JNK targets p53 ubiquitination and degradation in non-stressed cells, Genes Dev. 12 (1998) 2658-2663.
41. K. Furukawa, Q. Guo, G.D. Schellenberg, M.P. Mattson, Presenilin-1 mutations alter NGF-induced neurite outgrowth, calcium homeo-stasis, and transcription factor (AP-1) activation in PC12 cells, J. Neurosci. Res. 52 (1998) 618-624.
42. J. García-Piérez, J. Avila, J. Diaz-Nido, Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phos-phorylation of microtubule-associated protein 1B in developing neuronal cells, J. Neurosci. Res. 52 (1998) 445-452.
43. C. Geula, Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation, Neurology 51 (1 Suppl 1) (1998) S18-S29.
44. C. Geula, M. Mesulam, Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease, Brain Res. 498 (1989) 185-189.
45. C. Geula, C.K. Wu, D. Saroff, A. Lorenzo, M. Yuan, B.A. Yankner, Aging renders the brain vulnerable to amyloid β-protein neuro-toxicity, Nat. Med. 4 (1998) 827-831.
46. M. Gonzai lez, H. Jackle, Invagination centers within the Drosophila stomatogastric nervous system anlage are positioned by Notch-mediated signaling which is spatially controlled through wingless, Development 121 (1995) 2313-2325.
47. S. Govoni, S. Bergamaschi, M. Racchi et al., Cytosol protein kinase C down regulation in fibroblasts from Alzheimer's disease patients, Neurology 43 (1993) 2581-2586.
48. J.P. Greenfield, J. Tsai, G.K. Gouras et al., Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides, Proc. Natl. Acad. Sci. USA 96 (1999) 742-747.
49. I. Greenwald, LIN-12 INotch signaling: Lessons from worms and flies, Genes Dev. 12 (1998) 1751-1762.
50. C. Haass, Presenilins: Genes for life and death, Neuron 18 (1997) 687-690.
51. J.A. Hardy, G.A. Higgins, Alzheimer's disease: The amyloid cascade hypothesis, Science 256 (1992) 184-185.
52. J.D. Harper, P.T. Lansbury Jr., Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins, Annu. Rev. Biochem. 66 (1997) 385-407.
53. C.M. Hedgepeth, L.J. Conrad, J. Zhang, H.C. Huang, VM. Lee, P.S. Klein, Activation of the Wnt signaling pathway: A molecular mechanism for lithium action, Dev. Biol. 185 (1997) 82-91.
54. M. Hong, D.C.R. Chen, P.S. Klein, V.M.-Y. Lee, Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3, J. Biol. Chem. 272 (1997) 25326-25332.
55. A.Y. Hung, C. Haass, R.M. Nitsch et al., Activation ofprotein kinase C inhibits cellular production of the amyloid β-protein, J. Biol. Chem. 268 (1993) 22959-22962.
56. B.T. Hyman, K. Marzloff, P.V. Arriagada, The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggest a dynamic balance between amyloid deposition and resolution, J. Neuropathol. Exp. Neurol. 52 (1993) 594-600.
57. N.C. Inestrosa, A. Alvarez, C.A. Pérez et al., Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme, Neuron 16 (1996) 881-891.
58. N.C. Inestrosa, R. Alarcón, A. Alvarez et al., Molecular interactions of acetylcholinesterase with the synaptic basal lamina and the senile plaques, in: B.P. Doctor, D.M. Quinn, R.L. Rotundo, P. Taylor (Eds.), Cholinesterases and Related Proteins, Plenum Press, New York, NY, 1998.
59. N.I. Inestrosa, G.V De Ferrari, A.E. Reyes, F.J. Muñoz, C. Morgan, Molecular chaperones modulate amyloid β peptide assembly and neurotoxicity, FASEB J. 13 (1999) A1519, (Abstr.).
60. Y.T. Ip, R.J. Davis, Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development, Curr. Opin. Cell Biol. 10 (1998) 205-219.
61. M. Jonsson, K. Smith, A.L. Harris, Regulation of Wnt5a expression in human mammary cells by protein kinase C activity and the cytoskeleton, Br. J. Cancer 78 (1998) 430-438.
62. R.S. Jope, Anti-bipolar therapy: mechanism of action of lithium, Mol. Psychiatry 4 (1999) 117-128.
63. D.E. Kang, S. Soriano, M.P. Frosch et al., Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway, J. Neurosci. 19 (1999) 4229-4237.
64. R. Katzman, C. Kawas, The epidemiology of dementia and Alzheimer disease, in: R.D. Terry, R. Katzman, K.L. Bick (Eds.), Alzheimer Disease, Raven Press, New York, 1994, p. 105.
65. G.M. Kelly, P. Greenstein, D.F. Erezyilmaz, R.T. Moon, Zebrafish wnt8 and wnt8b share a common activity but are involved in distinct developmental pathways, Development 121 (1995) 1787-1799.
66. Y. Kitamura, S. Shimohama, W. Kamoshima, Y. Matsuoka, Y. Nomura, T. Taniguchi, Changes in p53 in the brains ofpatients with Alzheimer's disease, Biochem. Biophys. Res. Commun. 232 (1997) 418-421.
67. P.S. Klein, D.A. Melton, A molecular mechanism for the effect of lithium on development, Proc. Nat. Acad. Sci. USA 93 (1996) 8455-8459.
68. J. Klingensmith, Y. Yang, J.D. Axelrod, D.R. Beier, N. Perrimon, D.J. Sussman, Conservation of dishevelled structure and function between flies and mice: Isolation and characterization of Dvl2, Mech. Dev. 58 (1996) 15-26.
69. K.S. Kosik, Presenilin interactions and Alzheimer's disease, Science 279 (1998) 463-465.
70. D.M. Kovacs, R.E. Tanzi, Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations, Cell Mol. Life Sci. 54 (1998) 902-909.
71. D.M. Kovacs, H.J. Fausett, K.J. Page et al., Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells, Nat. Med. 2 (1996) 224-229.
72. V.M. Lee, J.Q. Trojanowski, Neurodegenerative tauopathies: human disease and transgenic mouse models, Neuron 24 (1999) 507-510.
73. M.K. Lee, H.H. Slunt, L.J. Martin et al., Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues, J. Neurosci. 16 (1996) 7513-7525.
74. S.J. Lee, U. Liyanage, P.E. Bickel, W. Xia, P.T. Lansbury Jr., K.S. Kosik, A detergent-insoluble membrane compartment contains Ab in vivo, Nat. Med. 4 (1998) 730-734.
75. J.-S. Lee, A. Ishimoto, S.-I. Yanagawa, Characterization of mouse Dishevelled (Dvl) proteins in WntIwingless signaling pathway, J. Biol. Chem. 274 (1999) 21464-21470.
76. D. Levitan, I. Greenwald, Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans, Development 125 (1998) 3599-3606.
77. L. Li, H. Yuan, W. Xie et al., Dishevelled proteins lead to two signaling pathways, J. Biol. Chem. 274 (1999) 129-134.
78. N. Lijam, R. Paylor, M.P. McDonald et al., Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1, Cell 90 (1997) 895-905.
79. A. Lorenzo, B.A. Yankner, β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red, Proc. Natl. Acad. Sci. USA 91 (1994) 12243-12247.
80. G.A. MacGibbon, P.A. Lawlor, M. Walton et al., Expression ofFos, Jun and Krox family proteins in Alzheimer's disease, Exp. Neurol. 147 (1997) 316-332.
81. E.-M. Mandelkow, E. Mandelkow, Tau in Alzheimer's disease, Trends Cell Biol. 8 (1998) 425-427.
82. H. Manji, W. Potter, R. Lenox, Signal transduction pathways: Molecular targets for lithiums actions, Arch. Gen. Psychiatry 52 (1995) 531-543.
83. D.L. Marcus, J.A. Strafaci, D.C. Miller et al., Quantitative neuronal c-fos and c-jun expression in Alzheimer's disease, Neurobiol. Aging 19 (1998) 393-400.
84. M.M. Mesulam, M.A. Moran, Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease, Ann. Neurol. 22 (1987) 223-228.
85. M.M. Mesulam, C. Geula, Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease, Ann. Neurol. 24 (1988) 765-773.
86. T. Miyaoka, T. Seno, H. Ishino, Increased expression of Wnt-1 in schizophrenic brains, Schizophr. Res. 38 (1999) 1-6.
87. F.J. Munoz, N.C. Inestrosa, Neurotoxicity of acetylcholinesterase amyloid β-peptide aggregates is dependent on the type of Ab peptide and the AChE concentration present in the complexes, FEBS Lett. 450 (1999) 205-209.
88. J.R. Muñoz-Montano, F.J. Moreno, J. Avila, J. Diaz-Nido, Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons, FEBS Lett. 411 (1997) 183-188.
89. M. Murayama, S. Tanaka, J. Palacino et al., Direct association of presenilin-1 with β-catenin, FEBS Lett. 433 (1998) 73-77.
90. S. Naruse, G. Thinakaran, J.-J. Luo et al., Effects of PS1 deficiency on membrane protein trafficking in neurons, Neuron 21 (1998) 1213-1221.
91. R.L. Neve, N. Robakis, Alzheimer's disease: A re-examination of the amyloid hypothesis, Trends Neurosci. 21 (1998) 15-19.
92. M. Nishimura, G. Yu, G. Levesque et al., Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex, Nat. Med. 5 (1999) 164-169.
93. R.M. Nitsch, B.E. Slack, R.J. Wurtman, J.H. Growdon, Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors, Science 258 (1992) 304-307.
94. S. Nonaka, D.M. Chuang, Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats, Neuroreport 9 (1998) 2081-2084.
95. R. Nusse, Wnt targets. Repression and activation, Trends Genet. 15 (1999) 1-3.
96. R. Nusse, H.E. Varmus, Wnt genes, Cell 69 (1992) 1073-1087.
97. B.A. Parr, A.P. McMahon, Wnt genes and vertebrate development, Curr. Opin. Genet. Dev. 4 (1994) 523-528.
98. B.A. Parr, M.J. Shea, G. Vassileva, A.P. McMahon, Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds, Development 119 (1993) 247-261.
99. J.J. Pei, T. Tanaka, Y.C. Tung, E. Braak, K. Iqbal, I. Grundke-Iqbal, Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain, J. Neuropathol. Exp. Neurol. 56 (1997) 70-78.
100. S.L. Pelech, Networking with proline-directed protein kinases implicated in tau phosphorylation, Neurobiol. Aging 16 (1995) 247-256.
101. C.P. Ponting, P. Bork, Pleckstrin's repeat performance: A novel domain in G-protein signaling?, Trends Biochem. Sci. 21 (1996) 245-246.
102. P. Poorkaj, T.D. Bird, E. Wijsman et al., Tau is a candidate gene for chromosome 17 frontotemporal dementia, Ann. Neurol. 43 (1998) 815-825.
103. J.L. Price, J.C. Morris, Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease, Ann. Neurol. 45 (1999) 358-368.
104. T. Ratovitski, H.H. Slunt, G. Thinakaran, D.L. Price, S.S. Sisodia, D.R. Borchelt, Endoproteolytic processing and stabilization of wild-type and mutant presenilin, J. Biol. Chem. 272 (1997) 24536-24541.
105. W.J. Ray, M. Yao, P. Nowotny et al., Evidence for a physical interaction between presenilin and Notch, Proc. Natl. Acad. Sci. USA 96 (1999) 3263-3268.
106. C.H. Reynolds, M.A. Utton, G.B. Gibb, A. Yates, B.H. Anderton, Stress-activated protein kinase Ic-jun N-terminal kinase phosphorylates tau protein, J. Neurochem. 68 (1997) 1736-1744.
107. J.P. Roperch, V. Alvaro, S. Prieur et al., Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression, Nat. Med. 4 (1998) 835-838.
108. E.J. Rulifson, S.S. Blair, Notch regulates wingless expression and is not required for reception of the paracrine wingless signal during wing margin neurogenesis in Drosophila, Development 121 (1995) 2813-2824.
109. D. Scheuner, C. Eckman, M. Jensen et al., Secreted amyloid β -protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat. Med. 2 (1996) 864-870.
110. D.J. Selkoe, Amyloid b-protein and the genetics of Alzheimer's disease, J. Biol. Chem. 271 (1996) 18295-18298.
111. D.J. Selkoe, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease, Trends Cell Biol. 8 (1998) 447-453.
112. D.J. Selkoe, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature 399 (1999) A23-A31.
113. M.V. Semenov, M. Snyder, Human dishevelled genes constitute a DHR-containing multigene family, Genomics 42 (1997) 302-310.
114. L.C. Sheldahl, M. Park, C.C. Malbon, R.T. Moon, Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner, Curr. Biol. 9 (1999) 695-698.
115. S. Shimohama, M. Narita, H. Matsushima et al., Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease, Neurology 43 (1993) 1407-1413.
116. D.M. Skovronsky, R.W. Doms, VM.-Y. Lee, Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture, J. Cell Biol. 141 (1998) 1031-1039.
117. D.C. Slusarski, V.G. Corces, R.T. Moon, Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling, Nature 390 (1997) 410-413.
118. M.A. Smith, K. Hirai, K. Hsiao et al., Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress, J. Neurochem. 70 (1998) 2212-2215.
119. C. Soto, M.C. Brafies, J. Alvarez, N.C. Inestrosa, Structural determinants of the Alzheimer's amyloid β-peptide, J. Neurochem. 63 (1994) 1191-1198.
120. C. Soto, E. Castafio, B. Frangione, N.C. Inestrosa, The a-helical to β -strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation, J. Biol. Chem. 270 (1995) 3063-3067.
121. V. Stambolik, L. Ruel, J.R. Woodgett, Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signaling in intact cells, Curr. Biol. 6 (1996) 1664-1668.
122. H. Steiner, K. Duff, A. Capell et al., A loss offunction mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling, J. Biol. Chem. 274 (1999) 28669-28673.
123. J.H. Su, B.J. Cummings, C.W. Cotman, Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites, Acta Neuropathol. (Berl) 96 (1998) 463-471.
124. D.J. Sussman, J. Klingensmith, P. Salinas, P.S. Adams, R. Nusse, N. Perrimon, Isolation and characterization of a mouse homolog of the Drosophila segment polarity gene dishevelled, Dev. Biol. 166 (1994) 73-86.
125. A. Takashima, K. Noguchi, K. Sato, T. Hoshino, K. Imahori, Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity, Proc. Natl. Acad. Sci. USA 90 (1993) 7789-7793.
126. A. Takashima, H. Yamaguchi, K. Noguchi et al., Amyloid b peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I Iglycogen synthase kinase-3b in rat hippocampal neurons, Neurosci. Lett. 198 (1995) 83-86.
127. A. Takashima, K. Noguchi, G. Michel et al., Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I Iglycogen synthase kinase-3b, Neurosci. Lett. 203 (1996) 33-36.
128. A. Takashima, M. Murayama, O. Murayama et al., Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau, Proc. Natl. Acad. Sci. USA 95 (1998) 9637-9641.
129. R. Terry, The cytoskeleton in Alzheimer disease, J. Neural Transm. 53 (Suppl.) (1998) 141-145.
130. H. Theisen, J. Purcell, M. Bennett, D. Kansagara, A. Syed, J.L. Marsh, dishevelled is required during wingless signaling to establish both cell polarity and cell identity, Development 120 (1994) 347-360.
131. G. Thinakaran, C.L. Harris, T. Ratovitski et al., Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors, J. Biol. Chem. 272 (1997) 28415-28422.
132. G. Thinakaran, J.B. Regard, C.M. Bouton et al., Stable association of presenilin derivatives and absence of presenilin interactions with APP, Neurobiol. Dis. 4 (1998) 438-453.
133. M. Tsang, N. Lijam, Y. Yang, D.R. Beier, A. Wynshaw-Boris, D.J. Sussman, Isolation and characterization of mouse dishevelled-3, Dev. Dyn. 207 (1996) 253-262.
134. T. Van Huynh, G. Cole, R. Katzman, K.P. Huang, T. Saitoh, Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts, Arch. Neurol. 46 (1989) 1195-1199.
135. I. Vincent, J.H. Zheng, D.W. Dickson, Y. Kress, P. Davies, Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease, Neurobiol. Aging 19 (1998) 287-296.
136. U. Wagner, J. Brownlees, N.G. Irving, F.R. Lucas, P.C. Salinas, C.C.J. Miller, Overexpression of the mouse dishevelled-1 protein inhibits GSK-3β-mediated phosphorylation of tau in transfected mammalian cells, FEBS Lett. 411 (1997) 369-372.
137. M. Waragai, I. Imafuku, S. Takeuchi et al., Presenilin 1 binds to amyloid precursor protein directly, Biochem. Biophys. Res. Com-mun. 239 (1997) 480-482.
138. A. Weidemann, K. Paliga, U. Durrwang et al., Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and β-amyloid precursor protein, Nat. Med. 3 (1997) 328-332.
139. A. Wodarz, R. Nusse, Mechanisms of Wnt signaling in development, Annu. Rev. Cell. Dev. Biol. 14 (1998) 59-88.
140. M.S. Wolfe, W. Xia, B.L. Ostaszewski, T.S. Diehl, W.T. Kimberly, D.J. Selkoe, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity, Nature 398 (1999) 513-517.
141. W. Xia, J. Zhang, R. Perez, E.H. Koo, D.J. Selkoe, Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease, Proc. Natl. Acad. Sci. USA 94 (1997) 8208-8213.
142. B.A. Yankner, L.K. Duffy, D.A. Kirschner, Neurotrophic and neurotoxic effects of amyloid 3β protein: reversal by tachykinin neuropeptides, Science 250 (1990) 279-282.
143. C. Yost, M. Torres, J.R. Miller, E. Huang, D. Kimelman, R.T. Moon, The axis-inducing activity, stability, and subcellular distribution of b-catenin is regulated in Xenopus embryos by glicogen synthase kinase 3, Genes Dev. 10 (1996) 1443-1454.
144. G. Yu, F. Chen, G. Levesque et al., The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains 3β-catenin, J. Biol. Chem. 273 (1998) 16470-16475.
145. L. Zeng, F. Fagotto, T. Zhang et al., The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation, Cell 90 (1997) 181-192.
146. Z. Zhang, H. Hartmann,V.M. Do et al., Destabilization of 3β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis, Nature 395 (1998) 698-702.
147. Q. Zheng-Fischhofer, J. Biernat, E.M. Mandelkow, S. Illenberger, R. Godemann, E. Mandelkow, Sequential phosphorylation of Tau by glycogen synthase kinase-33β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation, Eur. J. Biochem. 252 (1998) 542-552.
148. J. Zhou, U. Liyagane, M. Medina et al., Presenilin 1 interaction in the brain with a novel member of the armadillo family, NeuroReport 8 (1997) 2085-2090.